Budesonide
Modify Date: 2024-01-08 15:52:45
Budesonide structure
|
Common Name | Budesonide | ||
|---|---|---|---|---|
| CAS Number | 51372-29-3 | Molecular Weight | 430.534 | |
| Density | 1.3±0.1 g/cm3 | Boiling Point | 599.7±50.0 °C at 760 mmHg | |
| Molecular Formula | C25H34O6 | Melting Point | 194-199ºC | |
| MSDS | N/A | Flash Point | 201.8±23.6 °C | |
| Name | 16a(R),17-(Butylidenebis(oxy))-11b,21-dihydroxypregna-1,4-diene-3,20-dione |
|---|---|
| Synonym | More Synonyms |
| Density | 1.3±0.1 g/cm3 |
|---|---|
| Boiling Point | 599.7±50.0 °C at 760 mmHg |
| Melting Point | 194-199ºC |
| Molecular Formula | C25H34O6 |
| Molecular Weight | 430.534 |
| Flash Point | 201.8±23.6 °C |
| Exact Mass | 430.235535 |
| PSA | 93.06000 |
| LogP | 3.14 |
| Vapour Pressure | 0.0±3.9 mmHg at 25°C |
| Index of Refraction | 1.592 |
| Storage condition | -20°C Freezer |
| Hazard Codes | Xi |
|---|---|
| HS Code | 2914509090 |
|
~99%
Budesonide CAS#:51372-29-3 |
| Literature: SUN PHARMACEUTICAL INDUSTRIES LIMITED Patent: WO2005/44759 A2, 2005 ; Location in patent: Page/Page column 11 ; |
|
~%
Budesonide CAS#:51372-29-3 |
| Literature: Lenna, Roberto; Montoro, Maurizio Patent: US2009/259037 A1, 2009 ; Location in patent: Page/Page column 3-4 ; |
| Precursor 3 | |
|---|---|
| DownStream 0 | |
| HS Code | 2914509090 |
|---|---|
| Summary | HS:2914509090 other ketones with other oxygen function VAT:17.0% Tax rebate rate:9.0% Supervision conditions:none MFN tariff:5.5% General tariff:30.0% |
| Budesonide |
| Spirocort |
| Bidien |
| arachidonic acid ethanolamide |
| 2H-Naphth[2',1':4,5]indeno[1,2-d][1,3]dioxol-2-one, 4a,4b,5,6,6a,6b,9a,10,10a,10b,11,12-dodecahydro-5-hydroxy-6b-(2-hydroxyacetyl)-4a,6a-dimethyl-8-propyl-, (4aR,4bS,5S,6aS,6bS,9aR,10aS,10bS)- |
| N-arachidonoylethanolamide |
| (4aR,4bS,5S,6aS,6bS,8R,9aR,10aS,10bS)-5-Hydroxy-6b-(hydroxyacetyl)-4a,6a-dimethyl-8-propyl-4a,4b,5,6,6a,6b,9a,10,10a,10b,11,12-dodecahydro-2H-naphtho[2',1':4,5]indeno[1,2-d][1,3]dioxol-2-on |
| (4aR,4bS,5S,6aS,6bS,8R,9aR,10aS,10bS)-5-hydroxy-6b-(hydroxyacétyl)-4a,6a-diméthyl-8-propyl-4a,4b,5,6,6a,6b,9a,10,10a,10b,11,12-dodécahydro-2H-naphto[2',1':4,5]indéno[1,2-d][1,3]dioxol-2-one |
| Pulmicort |
| Rhinocort |
| 2H-naphth[2',1':4,5]indeno[1,2-d][1,3]dioxol-2-one, 4a,4b,5,6,6a,6b,9a,10,10a,10b,11,12-dodecahydro-5-hydroxy-6b-(hydroxyacetyl)-4a,6a-dimethyl-8-propyl-, (4aR,4bS,5S,6aS,6bS,8R,9aR,10aS,10bS)- |
| N-Arachidonoyl-2-hydroxyethylamide |
| (4aR,4bS,5S,6aS,6bS,8R,9aR,10aS,10bS)-6b-Glycoloyl-5-hydroxy-4a,6a-dimethyl-8-propyl-4a,4b,5,6,6a,6b,9a,10,10a,10b,11,12-dodecahydro-2H-naphtho[2',1':4,5]indeno[1,2-d][1,3]dioxol-2-one |
| Budeson |
| arachidonylethanolamide |
| 2H-Naphth[2',1':4,5]indeno[1,2-d][1,3]dioxol-2-one, 4a,4b,5,6,6a,6b,9a,10,10a,10b,11,12-dodecahydro-5-hydroxy-6b-(2-hydroxyacetyl)-4a,6a-dimethyl-8-propyl-, (4aR,4bS,5S,6aS,6bS,8R,9aR,10aS,10bS)- |
| ENTOCORT |
| dexbudesonide |
| (4aR,4bS,5S,6aS,6bS,9aR,10aS,10bS)-6b-Glycoloyl-5-hydroxy-4a,6a-dimethyl-8-propyl-4a,4b,5,6,6a,6b,9a,10,10a,10b,11,12-dodecahydro-2H-naphtho[2',1':4,5]indeno[1,2-d][1,3]dioxol-2-one |
| 2H-naphth[2',1':4,5]indeno[1,2-d][1,3]dioxol-2-one, 4a,4b,5,6,6a,6b,9a,10,10a,10b,11,12-dodecahydro-5-hydroxy-6b-(hydroxyacetyl)-4a,6a-dimethyl-8-propyl-, (4aR,4bS,5S,6aS,6bS,9aR,10aS,10bS)- |
| 5,8,11,14-Eicosatetraenoylethanolamide |
| (4aR,4bS,5S,6aS,6bS,8R,9aR,10aS,10bS)-5-hydroxy-6b-(hydroxyacetyl)-4a,6a-dimethyl-8-propyl-4a,4b,5,6,6a,6b,9a,10,10a,10b,11,12-dodecahydro-2H-naphtho[2',1':4,5]indeno[1,2-d][1,3]dioxol-2-one |
| N-arachidonoyl ethanolamine |
| arachidonoylethanolamide |
| Arachidonoyl-EA |
| 16a(R),17-(Butylidenebis(oxy))-11b,21-dihydroxy-pregna-1,4-diene-3,20-dione |